跳至主要内容
临床试验/IRCT20161010030246N5
IRCT20161010030246N5招募中3 期

Evaluating the effectiveness of pentoxifylline on the prevention of gentamicin nephrotoxicity in hospitalized patients in Shiraz

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age higher than 18 years
  • Receiving intravenous or intramuscular gentamicin for at least 1 week
  • No confirmed acute or chronic kidney injury
  • Do not take gentamicin intravenously or intramuscularly during the past 14 days
  • Do not take pentoxifylline orally during the past week
  • No confirmed history of allergic reactions to pentoxifylline
  • Informed consent form

排除标准

  • Patient with hemodynamic instability
  • Concomitant use of medicines or antioxidant compounds such as vitamin C, vitamin E, or vitamin A
  • Concomitant use of medications with high renal toxicity
  • No tolerant of oral medications

研究者

相似试验